1370525-02-2

Upstream product

• 30186-18-6 4'-bromo-2'-hydroxyacetophenone 
• 1246471-94-2 5-bromo-2-(5-bromo-1H-indol-2-yl)phenol 
• 104-88-1 4-chlorobenzaldehyde 
• 1369594-43-3 C₁₄H₁₂Br₂N₂O 

Downstream Products

• 1370525-03-3 C₂₂H₁₄Br₂ClNO 
• 1370525-04-4 C₂₂H₁₄Br₂ClNO 

Relevant academic research and scientific papers

FUSED TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

The present invention discloses novel Fused Tetracyclic Heterocycle Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, A', G, R1, R15, U, V, V', W, W', X, X', Y and Y' are as defined herein. The present invention also discloses compositions comprising at least one Fused Tetracyclic Heterocycle Compound, and methods of using the Fused Tetracyclic Heterocycle Compounds for treating or preventing HCV infection in a patient.

TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION

Tetracyclic heterocycle compounds of formula (I) and pharmaceutically acceptable salts thereof are provided, wherein A, A', G, R1, R15, U, V, V', W, W, X, X', Y and Y' are as defined in the invention. The pharmaceutical compositions comprising these compounds and the use of the compounds for treating hepatitis C virus (HCV) infection are also provided.